Novem Group S.A. carries a market capitalization of 117.04M, placing it among publicly traded companies globally. Its enterprise value stands at 227.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 117.04M |
| Enterprise Value | 227.80M |
Novem Group S.A. currently has 43.03M shares outstanding.
| Shares Outstanding | 43.03M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Novem Group S.A. trades at a trailing price-to-earnings ratio of 10.35. The price-to-sales ratio is 0.23, and the price-to-book ratio stands at -0.27.
| PE Ratio | 10.35 |
| PS Ratio | 0.23 |
| PB Ratio | -0.27 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | 1.68 |
| P/OCF Ratio | 2.05 |
On an enterprise value basis, Novem Group S.A. trades at an EV/EBITDA multiple of 12.20 and an EV/FCF ratio of 2.98. The EV/Sales ratio of 0.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.20 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.45 |
| EV / EBITDA | 12.20 |
| EV / EBIT | 12.20 |
| EV / FCF | 2.98 |
Novem Group S.A. maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 303.29, indicating elevated leverage, while an interest coverage ratio of 1.24 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.84 |
| Quick Ratio | 0.45 |
| Debt / Equity | 303.29 |
| Debt / EBITDA | 15.38 |
| Interest Coverage | 1.24 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 1.99 |
| Return on Invested Capital (ROIC) | 2.33 |
| Return on Capital Employed (ROCE) | -12.66 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.92 |
Over the trailing twelve months, Novem Group S.A. has paid 11.55M in income taxes, reflecting an effective tax rate of 51.03.
| Income Tax | 11.55M |
| Effective Tax Rate | 51.03 |
Novem Group S.A.'s stock has declined approximately -34.45783% over the past 52 weeks. The 50-day moving average sits at 2.63, while the 200-day moving average is 2.84.
| Beta (5Y) | N/A |
| 52-Week Price Change | -34.45783% |
| 50-Day Moving Average | 2.63 |
| 200-Day Moving Average | 2.84 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Novem Group S.A. generated 510.90M in revenue and converted that into 11.19M in net income, yielding earnings per share of 0.24. EBITDA reached 18.67M, while operating income came in at 18.67M.
| Revenue | 510.90M |
| Gross Profit | 249.40M |
| Operating Income | 18.67M |
| Pretax Income | 22.63M |
| Net Income | 11.19M |
| EBITDA | 18.67M |
| EBIT | 18.67M |
| Earnings Per Share (EPS) | 0.24 |
Novem Group S.A. holds 175.22M in cash and equivalents against 287.28M in total debt, resulting in a net debt position of 75.58M. Total book value stands at -433.08M, with working capital of -61.49M providing operational flexibility.
| Cash & Cash Equivalents | 175.22M |
| Total Debt | 287.28M |
| Net Debt | 75.58M |
| Equity (Book Value) | -433.08M |
| Book Value Per Share | -9.28 |
| Working Capital | -61.49M |
Novem Group S.A. produced 56.57M in operating cash flow over the past twelve months. After subtracting -12.49M in capital expenditures, free cash flow totaled 44.08M - equivalent to 0.94 per share.
| Operating Cash Flow | 56.57M |
| Capital Expenditures | -12.49M |
| Free Cash Flow | 44.08M |
| FCF Per Share | 0.94 |
Novem Group S.A. operates with a gross margin of 48.82, reflecting its pricing power and cost economics. The operating margin of 3.65 and net profit margin of 2.19 provide insight into operational efficiency.
| Gross Margin | 48.82 |
| Operating Margin | 3.65 |
| Pretax Margin | 4.43 |
| Profit Margin | 2.19 |
| EBITDA Margin | 3.65 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 20.04 |
| FCF Yield | 59.67 |
Novem Group S.A. posts an Altman Z-Score of -0.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.05 |